Utilizing the "frozen sections" technique, Mayo Clinic surgical and laboratory teams work together to provide patients immediate treatment by analyzing patients' tissue samples while they are still laying on the operating table under anesthesia. In addition to helping patients, this technique cuts cost by eliminating the need for follow-up surgery when analysis finds not all the cancerous tissue has been removed.
On Monday, August 11, the Food and Drug Administration announced its approval of the first stool-based colorectal screening test co-developed by Exact Sciences and Mayo Clinic. Exact Sciences will be the sole provider of this new test. While the test is based on Mayo Clinic research, the test will not be available through Mayo Medical Laboratories.
In the May issue of CAP TODAY, Minetta Liu, M.D., of the Department of Medical Oncology and the Department of Laboratory Medicine and Pathology at Mayo Clinic discusses the use of circulating tumor cell (CTC) enumeration in her clinical practice.
- Mayo Clinic Researchers Discover New Form of Cancer
- 2014 ASCO Annual Meeting
- Molecular Diagnosis Of Bone And Soft Tissue Tumors [Communiqué]
- Mayo Clinic and Mayo Medical Laboratories Launch 50-gene Cancer Panel Test [News]
- Next Generation Sequencing Panel for Solid Tumor Cancers [A Test in Focus]